Am J Psychiatry 1990; 147:207-210
Copyright © 1990 by American Psychiatric Association
Emergence of intense suicidal preoccupation during fluoxetine treatment
MH Teicher, C Glod and JO Cole
Department of Psychiatry, Harvard Medical School, MA.
Six depressed patients free of recent serious suicidal ideation developed
intense, violent suicidal preoccupation after 2-7 weeks of fluoxetine
treatment. This state persisted for as little as 3 days to as long as 3
months after discontinuation of fluoxetine. None of these patients had ever
experienced a similar state during treatment with any other psychotropic
drug.
This article has been cited by other articles:
|
|
|
|
 
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Focus,
January 1, 2008;
6(1):
69 - 79.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, and B. G. Druss
Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Arch Gen Psychiatry,
January 1, 2008;
65(1):
94 - 101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Am J Psychiatry,
October 1, 2007;
164(10):
1530 - 1538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Perlis, S. Purcell, M. Fava, J. Fagerness, A. J. Rush, M. H. Trivedi, and J. W. Smoller
Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study
Arch Gen Psychiatry,
June 1, 2007;
64(6):
689 - 697.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
References
PsychiatryOnline CME,
May 1, 2007;
2007(1):
2 - 2.
[Full Text]
|
|
|
|
|
|
|
P. A. Kurdyak, D. N. Juurlink, and M. M. Mamdani
The Effect of Antidepressant Warnings on Prescribing Trends in Ontario, Canada
Am J Public Health,
April 1, 2007;
97(4):
750 - 754.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. McKeown, S. P. Cuffe, and R. M. Schulz
US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends
Am J Public Health,
October 1, 2006;
96(10):
1744 - 1751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Healy
The antidepressant tale: figures signifying nothing?
Advan. Psychiatr. Treat.,
September 1, 2006;
12(5):
320 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Healy
Did regulators fail over selective serotonin reuptake inhibitors?
BMJ,
July 8, 2006;
333(7558):
92 - 95.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Juurlink, M. M. Mamdani, A. Kopp, and D. A. Redelmeier
The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Am J Psychiatry,
May 1, 2006;
163(5):
813 - 821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. E Kaizar, J. B Greenhouse, H. Seltman, and K. Kelleher
Do antidepressants cause suicidality in children? A Bayesian meta-analysis
Clinical Trials,
April 1, 2006;
3(2):
73 - 98.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. A. Hammad, T. Laughren, and J. Racoosin
Suicidality in pediatric patients treated with antidepressant drugs.
Arch Gen Psychiatry,
March 1, 2006;
63(3):
332 - 339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Edwards
Newer v. older antidepressants in long-term pharmacotherapy: REVISITING... PREVENTION OF RELAPSE AND RECURRENCE OF DEPRESSION
Advan. Psychiatr. Treat.,
May 1, 2005;
11(3):
184 - 194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Caballero and M. C. Nahata
Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children
Am. J. Health Syst. Pharm.,
April 15, 2005;
62(8):
864 - 867.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Fergusson, S. Doucette, K. C. Glass, S. Shapiro, D. Healy, P. Hebert, and B. Hutton
Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
BMJ,
February 19, 2005;
330(7488):
396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R Finley
Antidepressants, Suicide, and the FDA: A Loose Association
Ann. Pharmacother.,
October 1, 2004;
38(10):
1739 - 1742.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S Cohen
Antidepressants: An Avoidable and Solvable Controversy
Ann. Pharmacother.,
October 1, 2004;
38(10):
1743 - 1746.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gunnell and D. Ashby
Antidepressants and suicide: what is the balance of benefit and harm
BMJ,
July 3, 2004;
329(7456):
34 - 38.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Furlan, M. J. Kallan, T. T. Have, I. Lucki, and I. Katz
SSRIs Do Not Cause Affective Blunting in Healthy Elderly Volunteers
Am J Geriatr Psychiatry,
June 1, 2004;
12(3):
323 - 330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. H. Sharav
Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities
Journal of Disability Policy Studies,
January 1, 2004;
15(1):
50 - 59.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. R Hartnell, J. P Wilson, N. C Patel, and M L. Crismon
Adverse Event Reporting with Selective Serotonin-Reuptake Inhibitors
Ann. Pharmacother.,
October 1, 2003;
37(10):
1387 - 1391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Khan, S. Khan, R. Kolts, and W. A. Brown
Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA Reports
Am J Psychiatry,
April 1, 2003;
160(4):
790 - 792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Cem Atbasoglu, S. K. Schultz, and N. C. Andreasen
The Relationship of Akathisia With Suicidality and Depersonalization Among Patients With Schizophrenia
J Neuropsychiatry Clin Neurosci,
August 1, 2001;
13(3):
336 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. M. Anderson and J. G. Edwards
Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness
Advan. Psychiatr. Treat.,
May 1, 2001;
7(3):
170 - 180.
[Full Text]
|
|
|
|
|
|
|
F. M. Quitkin, J. G. Rabkin, J. Gerald, J. M. Davis, and D. F. Klein
Validity of Clinical Trials of Antidepressants
Am J Psychiatry,
March 1, 2000;
157(3):
327 - 337.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. C. Leon, M. B. Keller, M. G. Warshaw, T. I. Mueller, D. A. Solomon, W. Coryell, and J. Endicott
Prospective Study of Fluoxetine Treatment and Suicidal Behavior in Affectively Ill Subjects
Am J Psychiatry,
February 1, 1999;
156(2):
195 - 201.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. F. Dziegielewski and A. M. Leon
Psychopharmacological Treatment of Major Depression
Research on Social Work Practice,
July 1, 1998;
8(4):
475 - 490.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. J. Verkes, R. C. Van der Mast, M. W. Hengeveld, J. P. Tuyl, A. H. Zwinderman, and G. M.J. Van Kempen
Reduction by Paroxetine of Suicidal Behavior in Patients With Repeated Suicide Attempts But Not Major Depression
Am J Psychiatry,
April 1, 1998;
155(4):
543 - 547.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. M. Lane
SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment
J Psychopharmacol,
January 1, 1998;
12(2):
192 - 214.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. J. Goldstein and P. J Goodnick
Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics
J Psychopharmacol,
January 1, 1998;
12(4_suppl):
55 - S87.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Steiner, S. Steinberg, D. Stewart, D. Carter, C. Berger, R. Reid, D. Grover, D. Streiner, and The Canadian Fluoxetine/Premenstrual Dysphoria Col
Fluoxetine in the Treatment of Premenstrual Dysphoria
N. Engl. J. Med.,
June 8, 1995;
332(23):
1529 - 1534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J G. Edwards
Suicide and antidepressants
BMJ,
January 28, 1995;
310(6974):
205 - 206.
[Full Text]
|
|
|
|
|
|
|
R. Lane, D. Baldwin, and S. Preskorn
The SSRIs: advantages, disadvantages and differences
J Psychopharmacol,
January 1, 1995;
9(2_suppl):
163 - 178.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. F. Gram
Fluoxetine
N. Engl. J. Med.,
November 17, 1994;
331(20):
1354 - 1361.
[Full Text]
|
|
|
|
|
|
|
M.M. Robertson, M.T. Abou-Saleh, D.A. Harrison, B.L. Nairac, D.R.L. Edwards, T. Lock, R.A. Burns, and C.L.E. Katona
A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness
J Psychopharmacol,
January 1, 1994;
8(2):
98 - 103.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Healy
5-HT and physical illness
J Psychopharmacol,
January 1, 1993;
7(1):
107 - 111.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. T. Ramos, V. Gentil, and C. Gorenstein
Clomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'
J Psychopharmacol,
January 1, 1993;
7(3):
265 - 269.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. M. Goodwin
The effects of treatment on mortality in affective illness
J Psychopharmacol,
January 1, 1992;
6(2_suppl):
312 - 317.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1990
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
